Inge Ludwig

970 total citations
10 papers, 295 citations indexed

About

Inge Ludwig is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Inge Ludwig has authored 10 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in Inge Ludwig's work include Lymphoma Diagnosis and Treatment (7 papers), MRI in cancer diagnosis (6 papers) and Medical Imaging Techniques and Applications (3 papers). Inge Ludwig is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), MRI in cancer diagnosis (6 papers) and Medical Imaging Techniques and Applications (3 papers). Inge Ludwig collaborates with scholars based in Netherlands, Germany and United States. Inge Ludwig's co-authors include Rutger A. J. Nievelstein, Thomas C. Kwee, Marc Bierings, Henriëtte M. E. Quarles van Ufford, F. J. A. Beek, Rob Fijnheer, Cuno S.P.M. Uiterwaal, Malou A. Vermoolen, John M. H. de Klerk and Taro Takahara and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Journal of Magnetic Resonance Imaging.

In The Last Decade

Inge Ludwig

10 papers receiving 292 citations

Peers

Inge Ludwig

RNMI

PFM

HEMAT

ONCOL

NEURO

Patrick Fielding United Kingdom

E M Bellon United States

Eduardo Figueiredo Brazil

Yasuaki Kuginuki Japan

Sung-Nam Lim South Korea

M Reiser Germany

A. Schöggl Austria

Allison Pribnow United States

Tobias Geith Germany

Hiroyoshi Isoda Japan

Patrick Fielding United Kingdom

Inge Ludwig

127 ×0.6

RNMI

41 ×0.4

PFM

10 ×0.3

HEMAT

48 ×1.8

ONCOL

15 ×0.6

NEURO

Citations per year, relative to Inge Ludwig Inge Ludwig (= 1×) peers Patrick Fielding

Countries citing papers authored by Inge Ludwig

Since Specialization

Citations

This map shows the geographic impact of Inge Ludwig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Ludwig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Ludwig more than expected).

Fields of papers citing papers by Inge Ludwig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Ludwig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Ludwig. The network helps show where Inge Ludwig may publish in the future.

Co-authorship network of co-authors of Inge Ludwig

This figure shows the co-authorship network connecting the top 25 collaborators of Inge Ludwig. A scholar is included among the top collaborators of Inge Ludwig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge Ludwig. Inge Ludwig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Stege, Claudia A.M., Kazem Nasserinejad, Mark‐David Levin, et al.. (2018). Efficacy and Tolerability of Ixazomib, Daratumumab and Low Dose Dexamethasone (IDd) in Unfit and Frail Newly Diagnosed Multiple Myeloma (NDMM) Patients; First Interim Safety Analysis of the Phase II HOVON 143 Study. Blood. 132(Supplement 1). 596–596. 13 indexed citations

Kwee, Thomas C., Henriëtte M. E. Quarles van Ufford, F. J. A. Beek, et al.. (2015). Computed Tomography Observer Agreement in Staging Malignant Lymphoma. Journal of Computer Assisted Tomography. 40(2). 261–265. 1 indexed citations

Kwee, Thomas C., John M. H. de Klerk, Judit A. Adam, et al.. (2014). Relationship between pretreatment FDG-PET and diffusion-weighted MRI biomarkers in diffuse large B-cell lymphoma.. PubMed. 4(3). 231–8. 8 indexed citations

Adams, Hugo J.A., Thomas C. Kwee, Malou A. Vermoolen, et al.. (2013). Whole-body MRI vs. CT for staging lymphoma: Patient experience. European Journal of Radiology. 83(1). 163–166. 20 indexed citations

Kwee, Thomas C., Malou A. Vermoolen, Marie José Kersten, et al.. (2013). Whole‐body MRI, including diffusion‐weighted imaging, for staging lymphoma: Comparison with CT in a prospective multicenter study. Journal of Magnetic Resonance Imaging. 40(1). 26–36. 45 indexed citations

Nievelstein, Rutger A. J., Henriëtte M. E. Quarles van Ufford, Thomas C. Kwee, et al.. (2012). Radiation exposure and mortality risk from CT and PET imaging of patients with malignant lymphoma. European Radiology. 22(9). 1946–1954. 71 indexed citations

Kwee, Thomas C., Erik M. Akkerman, Rob Fijnheer, et al.. (2011). MRI for staging lymphoma: Whole‐body or less?. Journal of Magnetic Resonance Imaging. 33(5). 1144–1150. 6 indexed citations

Kwee, Thomas C., Inge Ludwig, Cuno S.P.M. Uiterwaal, et al.. (2010). ADC measurements in the evaluation of lymph nodes in patients with non-Hodgkin lymphoma: feasibility study. Magnetic Resonance Materials in Physics Biology and Medicine. 24(1). 1–8. 26 indexed citations

Kwee, Thomas C., Henriëtte M. E. Quarles van Ufford, F. J. A. Beek, et al.. (2009). Whole-Body MRI, Including Diffusion-Weighted Imaging, for the Initial Staging of Malignant Lymphoma. Investigative Radiology. 44(10). 683–690. 83 indexed citations

10.

Sonke, Gabe S., Inge Ludwig, Joke W. Baars, et al.. (2008). Poor Outcomes of Chronic Active Epstein‐Barr Virus Infection and Hemophagocytic Lymphohistiocytosis in Non‐Japanese Adult Patients. Clinical Infectious Diseases. 47(1). 105–108. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact